Chicago sky blue 6B, a vesicular glutamate transporters inhibitor, attenuates methamphetamine-induced hyperactivity and behavioral sensitization in mice

Behavioural Brain Research

Volumn 239, Issue 1, 2013, Pages 172-176

  He, Zongsheng ^a,b   Yan, Lingdi ^a   Yong, Zheng ^a   Dong, Zhaoqi ^a,c   Dong, Huajin ^a   Gong, Zehui ^a  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c JIANGNAN UNIVERSITY   (China)

Author keywords

Chicago sky blue 6B; Hyperactivity; Methamphetamine; Sensitization; Vesicular glutamate transporters

Indexed keywords

CHICAGO SKY BLUE 6B; GLUTAMATE RECEPTOR ANTAGONIST; METHAMPHETAMINE; PLACEBO; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER INHIBITOR;

ABNORMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR THERAPY; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; DRUG SCREENING; DRUG TARGETING; EXPERIMENTAL MOUSE; HYPERACTIVITY; LOCOMOTION; MALE; METHAMPHETAMINE DEPENDENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANIMALS, OUTBRED STRAINS; BEHAVIOR, ADDICTIVE; CENTRAL NERVOUS SYSTEM SENSITIZATION; DRUG INTERACTIONS; HYPERKINESIS; INJECTIONS, INTRAVENTRICULAR; MALE; METHAMPHETAMINE; MICE; MOTOR ACTIVITY; TRYPAN BLUE; VESICULAR GLUTAMATE TRANSPORT PROTEINS;

EID: 84872259147     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.11.003     Document Type: Article

References (23)

1. Scott J.C., Woods S.P., Matt G.E., Meyer R.A., Heaton R.K., Atkinson J.H., et al. Neurocognitive effects of methamphetamine: a critical review and metaanalysis. Neuropsychology Review 2007, 17:275-297.
2. Caligiuri M.P., Buitenhuys C. Do preclinical findings of methamphetamine-induced motor abnormalities translate to an observable clinical phenotype?. Neuropsychopharmacology 2005, 30:2125-2134.
3. Stolerman I. Drugs of abuse: behavioural principles, methods and terms. Trends in Pharmacological Sciences 1992, 13:170-176.
4. Baucum A.J., Rau K.S., Riddle E.L., Hanson G.R., Flekenstein A.E. Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine and hyperthermia-associated mechanism. Journal of Neuroscience 2004, 24:3436-3443.
5. Sandoval V., Riddle E.L., Ugarte Y.V., Hanson G.R., Flekenstein A.E. Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model. Journal of Neuroscience 2001, 21:1413-1419.
6. Earle M.L., Davies J.A. Activation of metabotropic glutamate 2/3 receptors attenuates methamphetamine-induced hyperlocomotion and increase in prefrontal serotonergic neurotransmission. Psychopharmacology 2011, 217:443-452.
7. Simoes P.F., Silva A.P., Pereira F.C., Marques E., Milhazes N., Borges F., et al. Methamphetamine changes NMDA and AMPA glutamate receptor subunit levels in the rat striatum and frontal cortex. Annals of the New York Academy of Sciences 2008, 1139:232-241.
8. Reichel C.M., Schwendt M., McGinty J.F., Olive M.F., See R.E. Loss of object recognition memory produced by extended access to methamphetamine self-administration is reversed by positive allosteric modulation of metabotropic glutamate receptor 5. Neuropsychopharmacology 2011, 36:782-792.
9. Tanaka K., Watase K., Manabe T., Yamada K., Watanabe M., Takahashi K., et al. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 1997, 276:1699-1702.
10. Liguz-Lecznar M., Shangiel-Kramska J. Vesicular glutamate transporters (VGLUTs): the three musketeers of glutamatergic system. Acta Neurobiologiae Experimentalis 2007, 67:207-218.
11. Fujio M., Nakagawa T., Sekiya Y., Ozawa T., Suzuki Y., Minami M., et al. Gene transfer of GLT-1, a glutamate transporter, into the nucleus accumbens shell attenuates methamphetamine and morphine-induced conditioned place preference in rats. European Journal of Neuroscience 2005, 22:2744-2754.
12. Nakagawa T., Fujio M., Ozawa T., Minami M., Satoh M. Effect of MS-153, a glutamate transporter activator, on the conditioned rewarding effects of morphine, methamphetamine and cocaine in mice. Behavioural Brain Research 2005, 156:233-239.
13. Fujio M., Nakagawa M., Suzuki Y., Satoh M., Kaneko S. Facilitative effect of a glutamate transporter inhibitor (2S,3S)-3-{3-[4-(trifluoromethyl)benzoylamino]benzyloxy}aspartate on the expression of methamphetamine-induced behavioral sensitization in rats. Journal of Pharmacological Sciences 2005, 99:415-418.
14. Nash J.F., Yamamoto B.K. Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine. Brain Research 1992, 581:237-243.
15. Mark K.A., Quinton M.S., Russek S.J., Yamamoto B.K. Dynamic changes in vesicular glutamate transporter 1 function and expression related to methamphetamine-induced glutamate release. Journal of Neuroscience 2007, 27:6823-6831.
16. Roseth S., Fykse E.M., Fonnum F. Uptake of l-glutamate into rat brain synaptic vesicles: effect of inhibitors that bind specifically to the glutamate transporter. Journal of Neurochemistry 1995, 65:96-103.
17. Baghbanzadeh A., Modirsaneie M., Emam G., Hajinezhad M. Microhandling of vesicular glutamate uptake modulate feeding in broilers. Journal of Animal Physiology and Animal Nutrition (Berlin) 2010, 94:74-77.
18. 2 receptors mediated antinociception in mice. Neuropharmacology 2012, 62:855-864.
19. 1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice. Neuropharmacology 2006, 51:914-922.
20. Zhao W.L., Gong Z.H., Liang J.H. A new buprenorphine analogy, thenorphine, inhibits morphine-induced behavioral sensitization in mice. Acta Pharmacologica Sinica 2004, 25:1413-1418.
21. Cador M., Bjijou Y., Stinus L. Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. Neuroscience 1995, 65:385-395.
22. Vanderschuren L.J., Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology 2000, 151:99-120.
23. Ernst T., Chang L.D. Adaptation of brain glutamate plus glutamine during abstinence from chronic methamphetamine use. Journal of Neuroimmune Pharmacology 2008, 3:165-172.